Group 1 - A class action securities lawsuit has been filed against Telix Pharmaceuticals Ltd. to recover losses for shareholders affected by alleged securities fraud between February 21, 2025, and August 28, 2025 [2][3] - The complaint alleges that the defendants made false statements regarding Telix's progress with prostate cancer therapeutic candidates, overstated the quality of its supply chain and partners, and that these statements were materially false and misleading [3] - Shareholders who suffered losses during the relevant time frame are encouraged to learn about their rights to seek recovery, with no cost or obligation to participate [4] Group 2 - Levi & Korsinsky LLP is a nationally recognized securities litigation firm with a track record of securing hundreds of millions of dollars for shareholders and has been ranked among the top securities litigation firms in the United States for seven consecutive years [5]
Class Action Lawsuit Filed Against Telix Pharmaceuticals Ltd. (TLX) - Recover Losses - Contact Levi & Korsinsky Before January 9, 2026